Bisaillon J G, McSween G, Portelance V, Kluepfel D, Micusan V V
Can J Microbiol. 1982 Sep;28(9):1022-31. doi: 10.1139/m82-153.
Cross-protection has already been demonstrated in mice after vaccination with a CaCl2 extract from the Neisseria meningitidis group Y Slaterus strain. The immunogenicity of such extracts from group Y cells, cultivated in a fermenter in Neisseria chemically defined medium, against virulent groups A, B, and C meningococci has been evaluated by two different animal models and a microbactericidal procedure. The mouse challenge system has revealed that the active cross-production observed 7 days after a single immunization with the extract was probably nonspecific, since bacillus Calmette-Guérin gave similar results. However, after three vaccinations, active cross-protection was observed, mainly against the strains of groups B and C, for at least 35 days after the last injection. In the mouse bacteremia model, the extract had a protective effect mainly against the homologous group Y strain but in a few experiments a significant protection was also obtained against the strains of groups A and B. The microbactericidal test revealed that even after three injections of mice, guinea pigs, or humans with the extract only the homologous bactericidal activity was induced. Since there was no close correlation between the results obtained with the two animal models and also with the microbactericidal procedure, no definitive conclusion can be drawn on the protective potential of our extract.
用来自脑膜炎奈瑟菌Y群斯莱特鲁斯菌株的氯化钙提取物对小鼠进行疫苗接种后,已证明存在交叉保护作用。在化学限定培养基中于发酵罐中培养的Y群细胞的此类提取物对A、B和C群强毒脑膜炎球菌的免疫原性,已通过两种不同的动物模型和一种微生物杀菌程序进行了评估。小鼠攻毒系统显示,单次用提取物免疫7天后观察到的活性交叉产生可能是非特异性的,因为卡介苗也给出了类似结果。然而,三次接种后,观察到了活性交叉保护作用,主要针对B群和C群菌株,在最后一次注射后至少35天内有效。在小鼠菌血症模型中,提取物主要对同源Y群菌株有保护作用,但在少数实验中,对A群和B群菌株也获得了显著保护。微生物杀菌试验显示,即使对小鼠、豚鼠或人类三次注射提取物后,也仅诱导出同源杀菌活性。由于两种动物模型以及微生物杀菌程序所获得的结果之间没有密切相关性,因此无法就我们提取物的保护潜力得出明确结论。